![Valerie Kanter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Valerie Kanter
Directeur Technique/Scientifique/R&D chez DentaCell Accelerator
Profil
Valerie Kanter has a current job as the Director, Chief Medical & Scientific Officer at DentaCell Accelerator.
Postes actifs de Valerie Kanter
Sociétés | Poste | Début |
---|---|---|
DentaCell Accelerator
![]() DentaCell Accelerator Medical SpecialtiesHealth Technology DentaCell Accelerator is an organization that was converted into an accelerator in 2017 to address innovations in dentistry and support multiple startup launches simultaneously. The company is based in Los Angeles, CA. The company provides access to Leonhardt's Launchpads' building IP estate in stem cell, growth factors, micro pumps, and bioelectric stimulation technologies. The company also offers access to Cal-X Stars Business Accelerator, Inc. network of successful entrepreneurs, investors, mentors, and corporate partners. The company focuses on electroceutical treatment of pseudomonas aeruginosa biofilms. The company was founded in 2014, and the CEO is Howard J. Leonhardt. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
DentaCell Accelerator
![]() DentaCell Accelerator Medical SpecialtiesHealth Technology DentaCell Accelerator is an organization that was converted into an accelerator in 2017 to address innovations in dentistry and support multiple startup launches simultaneously. The company is based in Los Angeles, CA. The company provides access to Leonhardt's Launchpads' building IP estate in stem cell, growth factors, micro pumps, and bioelectric stimulation technologies. The company also offers access to Cal-X Stars Business Accelerator, Inc. network of successful entrepreneurs, investors, mentors, and corporate partners. The company focuses on electroceutical treatment of pseudomonas aeruginosa biofilms. The company was founded in 2014, and the CEO is Howard J. Leonhardt. | Health Technology |